#52: 🌈 The Promise of Psychedelics in Addressing Alzheimer's and Associated Symptoms
#52: 🌈 The Promise of Psychedelics in Addressing Alzheimer's and Associated Symptoms
This is your brain on drugs, in a good way
Hey Friends,
Next week on October 3, 2023, I’m speaking on a panel called “Say YES to Health and Longevity” brought to you by RedBridge, a community of Portuguese and Californians.
Get your ticket now, come say hi and ask any questions you have about living a long and healthy life.
See you there!
Nina
💬 In this note:
🌈 The Promise of Psychedelics in Addressing Alzheimer's and Associated Symptoms
📚 Friends, Lovers, and the Big Terrible Thing
⚡️ Colored Words
🌈 The Promise of Psychedelics in Addressing Alzheimer's and Associated Symptoms
Photo by Robina Weermeijer on Unsplash
Psychedelics have specific drug actions, such as inducing structural and functional neural plasticity, that could potentially treat mental health conditions and impact diseases affecting the brain, like Alzheimer's disease.
Alzheimer’s Disease (AD) is a brain disorder, typically occurring in seniors, that disrupts the communication between neurons and causes cell death. It is usually found in brain regions responsible for memory, learning and attention.
This interruption of signals is caused by a buildup of harmful proteins called neurofibrillary tangles and amyloid-beta, which cause inflammation in the brain.
Reducing Brain Inflammation with Psychedelics
To ease inflammation in the brain, researchers have suggested activation of the serotonin receptor (5-HT2A). Classic psychedelics have been shown to target and activate the 5-HT2A receptor.
Regions of the brain susceptible to Alzheimer’s, such as the hippocampus and the prefrontal cortex, have high concentrations of the 5-HT2A receptor.
Activating the 5-HT2A receptor could result in a decrease in the inflammation and cognitive decline associated with Alzheimer’s disease. Furthermore, activating the 5-HT2A receptors can release chemical signals that help form new nerve cells and strengthen their connections. This may help reverse the loss of cell function and cell death that occurs in Alzheimer’s.
Studies in rats and humans have shown that activating the 5-HT2A receptor via psychedelics reduces brain inflammation while improving memory, learning and focus.
Psychedelics To Slow Down Or Reverse Brain Atrophy
The atrophy of dendritic spines (the arms of brain cells) and reduction of synapse density are hallmarks of Alzheimer’s disease, and neuronal atrophy underlies many of the symptoms of neurodegenerative diseases related to mood, memory and cognition.
Recent evidence has shown that stimulation of the 5-HT2A receptors promote growth of neurons, making psychedelics attractive experimental treatments for neurodegenerative diseases.
In addition to activating the 5-HT2A receptor, psychedelics activate the receptor mTOR (mammalian target of rapamycin) which is involved in neuron growth and survival.
Suggesting that activation of these receptors with psychedelics may slow the progression of neurodegenerative diseases and alleviate the psychological symptoms associated with the disease.
Potential Treatments for Behavioral and Psychological Symptoms of Alzheimer’s
Not only do psychedelics possess the potential to advance cognitive performance in Alzheimer's patients. They can also help treat the depression and decreasing quality of life associated with Alzheimer’s.
Approximately 40% of patients with Alzheimer’s have anxiety. Recent studies have suggested that anti-anxiety and depression medications such as SSRIs or talk therapy are less effective in individuals with dementia. Alternative therapies, such as psychedelics, could be useful for individuals living with Alzheimer’s Disease and related dementias (ADRDs).
Drs. Albert Garcia-Romeu and Paul B. Rosenberg conduct psychedelic clinical research at the Center for Psychedelic & Consciousness Research at Johns Hopkins University. They are investigating if psychedelics can help people living with ADRDs cope with their condition.
While the therapeutic effects of psychedelics for ADRDs remain unproven, researchers believe psychedelics could positively impact the neurological causes of ADRDs or its associated psychiatric symptoms.
The Hopkins team is conducting the first study of its kind in people with ADRDs. They have a clinical trial recruiting for the use of psilocybin for depression in people with mild cognitive impairment or early Alzheimer’s Disease and another related trial is investigating psilocybin therapy for depression and anxiety in Parkinson’s Disease.
According to ClinicalTrials.gov, no clinical trials are listed to study the effect of psychedelics directly for the treatment of neurodegenerative diseases like Alzheimer’s or Parkinson’s, only studies for the management and treatment of depression and anxiety related to ADRDs.
The potential of psychedelics in treating Alzheimer's Disease offers a promising avenue for future research. While preliminary findings are encouraging, especially in addressing both neurological and psychological symptoms, further studies are essential. The journey towards understanding and possibly harnessing these substances for neurodegenerative diseases is just beginning.
📚 Book of the Week
Friends, Lovers and The Big Terrible Thing by Matthew Perry
Rating: ★★★★☆
Matthew Perry, the actor who brought us the beloved character Chandler Bing on the iconic TV series Friends, has revealed heartbreaking truths in his memoir, “Friends, Lovers and The Big Terrible Thing.”
In this brutally honest account of his life, Perry takes readers on a rollercoaster journey through his relentless struggle with alcohol and opioid addiction. At just 54 years old, Perry’s life has been a tumultuous battle against addiction. He lays it bare, chronicling his astonishing 6,000 AA meetings, 15 stints in rehab, 65 detoxes and being on life support.
He has spent between $7-$9 million trying to get sober.
Reading Perry’s memoir is a challenging experience, as it unveils the depth of his personal anguish while simultaneously portraying the entertainer who brought joy to hundreds of millions of people worldwide. His talent to get on stage and make audiences laugh each week on Friends stands in stark contrast to the anguish he concealed behind the scenes.
The most astonishing aspect of his story is the sheer miracle of his survival. Perry reveals that at one point he was consuming a mind-boggling 1800mg of hydrocodone a day just to maintain a semblance of normalcy. A typical dose is 10mg of hydrocodone every 12 hours. Perry’s daily consumption was approximately 100 times more showcasing the severity of his addiction.
This book is a must-read for Friends fans and anyone seeking insight into the hidden struggles of a favorite celebrity.
⚡️ Check This Out
This website asks you to associate a color with a word.
What color is Happiness?
What color is the number 8?
You select a color in a color graph and then you can see what colors other people chose.
The results are fascinating.